DuP 753, the selective angiotensin II receptor blocker, is a competitive antagonist to human platelet thromboxane A2/prostaglandin H2 (TP) receptors
- 1 August 1992
- journal article
- Published by Elsevier in Prostaglandins
- Vol. 44 (2) , 89-99
- https://doi.org/10.1016/0090-6980(92)90070-a
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Nonpeptide angiotensin II receptor antagonistsTrends in Pharmacological Sciences, 1991
- Role of endothelium-derived prostanoid in angiotensin-induced vasoconstriction.Hypertension, 1991
- Further studies on the selectivity of DuP 753, a nonpeptide angiotensin II receptor antagonistEuropean Journal of Pharmacology, 1991
- Role of prostanoids in renin-dependent and renin-independent hypertension.Hypertension, 1991
- Aspirin lowers blood pressure in patients with renovascular hypertension.Hypertension, 1989
- Receptors for angiotensin I1 on platelets from manClinical Science, 1984
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949
- A new mathematical treatment of changes of ionic concentration in muscle and nerve under the action of electric currents, with a theory as to their mode of excitationThe Journal of Physiology, 1910